June 11, 2025 8-Week Oral Therapy Approved for Acute HCV The FDA has approved Mavyret for the treatment of acute hepatitis C, offering physicians a pangenotypic, 8-week oral regimen for early intervention. Conexiant
June 10, 2025 Study Shows Potential Benefits of AI-Assisted Classification in HER2-Low and HER2-Ultralow Breast Cancer The ASCO Post
June 10, 2025 Structured Exercise Program Improves Survival Outcomes in Patients With Stage III or High-Risk Stage II Colon Cancer The ASCO Post
May 09, 2025 Is Active Monitoring a Safe Option for Patients With Ductal Carcinoma In Situ? The ASCO Post
June 01, 2025 Survival of a Maxillary Incisor in an Adolescent Female Patient 10 Years After Delayed Replantation Compendium
June 02, 2025 Industry Insights: Mark L. Baum, Founder and Chief Executive Officer, Harrow Optometric Management